Wenxing Feng has represented clients in more than 50 public and private company acquisitions, joint ventures, financings, and pre-IPO investments. His practice focuses on M&A, capital markets (including listings and public offerings), securities regulatory compliance, joint ventures, and other commercial transactions across Hong Kong, mainland China, and the Asia-Pacific region. He has extensive experience in a wide variety of industry sectors, including banking and financial services, health care, biotech, retail, real estate, and manufacturing.
Prior to joining Jones Day in 2017, Wenxing practiced at an international law firm, where he acted for China CNR Corporation Limited in its US$26 billion merger with CSR Corporation Limited, which was the first merger of two companies listed in both Hong Kong and Shanghai. In addition, he worked on many IPOs including those of Genscript Biotech Corporation, China CNR Corporation, and Guodian Technology and Environment Group Corporation Limited.
GenScript Biotech Corporation completes placement of shares
Jones Day advised GenScript Biotech Corporation (the “GenScript”, together with its subsidiaries, the “GenScript Group”), a company listed on The Stock Exchange of Hong Kong Limited, on its US$255 million top-up placing of shares and Ms. Ye Wang, a director, president, and controlling shareholder of GenScript on her US$51 million placing of shares.
CCB International Asset Management invests in Xinming China Holdings Limited
Jones Day represented CCB International Asset Management Limited in connection with its investment in Xinming China Holdings Limited, an investment holding company principally engaged in property development, via the purchase of convertible bonds.
Haitong International Financial Products invests $25 million in Youyuan International Holdings
Jones Day represented Haitong International Financial Products (Singapore) Pte Ltd in connection with its subscription of $25 million of Notes in Youyuan International Holdings Limited, a China-based wrapping tissue paper manufacturer.
Haitong International Financial Products invests $20 million in Burwill Holdings Limited
Jones Day represented Haitong International Financial Products (Singapore) Pte Ltd in connection with its subscription of $20 million of 7% Convertible Bonds in Burwill Holdings Limited, a Hong Kong-based investment holding company principally engaged in steel trading.
The following represents experience acquired prior to joining Jones Day.
Represented the sole sponsor, Haitong International Capital Limited, and the underwriters, Haitong International Securities Company, J.P. Morgan Securities (Asia Pacific), J.P. Morgan Securities, KGI Capital Asia, and RHB Securities Hong Kong, in relation to life science research and application services company Genscript Biotech Corporation's HK$524million IPO on The Stock Exchange of Hong Kong.
Represented Haitong International Securities Company Limited as underwriter in relation to the listing of BBI Life Sciences Corporation (a Chinese company that develops, manufactures, and sells life sciences products used in scientific research) on the Main Board of The Stock Exchange of Hong Kong.
Represented China CNR Corporation Limited (a rolling stock manufacturer) in its US$1.2 billion H-share IPO on The Stock Exchange of Hong Kong.
Represented CICC, UBS, and RBS as joint bookrunners on the US$300 million initial public offering and Rule 144A/Regulation S global offering of Guodian Technology and Environment Group Corporation Limited (the largest environmental protection and energy conservation solutions provider for coal-fired power plants operating in China).
Represented CCB International Asset Management Limited and Credit China Holdings Limited in its investment in Firefly Games through the subscription of US$10 million Series B preferred shares issued by the parent company. Firefly Games is a U.S.-based company that primarily engages in third-party distribution of games, independent R&D, and BI tools and systems for games and other business. The company obtained the exclusive authorization for its game distribution rights in China from DreamWorks to make 12 animations into mobile phone games, including Kung Fu Panda, How to Train Your Dragon, Shrek, Madagascar, and other famous intellectual properties.
Represented Crosby Securities Limited as placing agent on the issue of a bond of HK$100 million by Skyfame Realty (Holdings) Limited (Stock Code: 59), a company listed on the Main Board of The Stock Exchange of Hong Kong. The listed company is principally engaged in property development, property investment, hotel operation, and provision of ancillary services in Hong Kong and the PRC.
Represented CCB International Asset Management Limited on its HK$100 million pre-IPO investment in a PRC-based company by way of subscription of strict bond and exchangeable bond issued by its controlling shareholder. The company is primarily focused on the manufacturing and sales of plasma-derived biopharmaceuticals in China.
Represented financial advisor Haitong International Capital Limited in the acquisition by Leyou Technologies Holdings Limited (which engages in the development, distribution, and operation of online games), including the completed acquisition of Digital Extremes, a Canadian online game developer and operator, and its subsidiaries, and the acquisition of Splash Damage Limited, Warchest Limited, and Fireteam Limited in the U.K., for a total consideration of approximately US$160 million. Leyou Technologies (Stock Code: 1089) is listed on the Main Board of The Stock Exchange of Hong Kong.
- University of International Business and Economics (LL.M. 2012); Shandong University (LL.B. 2009; B.A. 2009)
- Hong Kong (registered foreign lawyer)